Elevance Health, Inc. announced on March 10, 2026, that it expects its adjusted earnings for full year 2026 to be at least $25.50 per diluted share, while reaffirming its benefit expense ratio guidance of 90.2%, including potential impacts from sanctions by CMS effective March 31, 2026.